Previous studies have revealed that the PI3K/Akt signaling pathway is frequently activated during glioma progression and its downstream target NF-κB is a well-known contributor to chemoresistance [21,22], thus we examined the effect of ABCE1 down-regulation on the PI3K/Akt/NF-κB pathway. This evidence concerns the gene ABCE1 and glioma.